{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T01:05:12Z","timestamp":1775955912711,"version":"3.50.1"},"reference-count":32,"publisher":"BMJ","issue":"5","funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["G0701757"],"award-info":[{"award-number":["G0701757"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["084840"],"award-info":[{"award-number":["084840"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Sex Transm Infect"],"accepted":{"date-parts":[[2018,11,25]]},"published-print":{"date-parts":[[2019,8]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>To estimate the prevalence of, and describe risk factors for, genital warts (GWs) in the British population, following the introduction of the bivalent (human papillomavirus (HPV)-16\/18) vaccination programme in girls, and prior to the switch to quadrivalent (HPV-6\/11\/16\/18) vaccine (offering direct protection against GWs) and compare this with GW diagnoses in the prevaccination era.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Natsal-3, a probability sample survey in Britain, conducted in 2010\u20132012, interviewed 9902 men and women aged 16\u201344. Natsal-2, conducted in 1999\u20132001, surveyed 11\u2009161 men and women aged 16\u201344. Both surveys collected data on sexual behaviour and sexually transmitted infection diagnoses using computer-assisted interview methods.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In Natsal-3, 3.8% and 4.6% of sexually experienced men and women reported ever having a diagnosis of GWs, with 1.3% of men and 1.7% of woman reporting a GWs diagnosis in the past 5 years. GWs were strongly associated with increasing partner numbers and condomless sex. Diagnoses were more frequent in men who have sex with men (MSM) (11.6% ever, 3.3% past 5 years) and in women reporting sex with women (10.8% ever, 3.6% past 5 years). In the age group who were eligible for vaccination at the time of Natsal-3 (16\u201320 years), a similar proportion of same-aged women reported a history of GWs in Natsal-2 (1.9%, 1.1\u20133.4) and Natsal-3 (2.6%, 1.5\u20134.4).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>These data provide essential parameters for mathematical models that inform cost-effectiveness analyses of HPV vaccination programmes. There was no evidence of population protection against GWs conferred by the bivalent vaccine. Even with vaccination of adolescent boys, vaccination should be offered to MSM attending sexual health clinics.<\/jats:p><\/jats:sec>","DOI":"10.1136\/sextrans-2018-053786","type":"journal-article","created":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T22:15:25Z","timestamp":1549404925000},"page":"386-390","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":19,"title":["Epidemiology of genital warts in the British population: implications for HPV vaccination programmes"],"prefix":"10.1136","volume":"95","author":[{"given":"Pam","family":"Sonnenberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clare","family":"Tanton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Mesher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleanor","family":"King","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Beddows","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nigel","family":"Field","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine H","family":"Mercer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate","family":"Soldan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne M","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2019,2,5]]},"reference":[{"key":"2024092304402302000_95.5.386.1","doi-asserted-by":"publisher","DOI":"10.2217\/fmb.14.110"},{"key":"2024092304402302000_95.5.386.2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-13-39"},{"key":"2024092304402302000_95.5.386.3","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2010.048421"},{"key":"2024092304402302000_95.5.386.4","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2011-050073"},{"key":"2024092304402302000_95.5.386.5","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-10-137"},{"key":"2024092304402302000_95.5.386.6","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw354"},{"key":"2024092304402302000_95.5.386.7","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2009.037788"},{"key":"2024092304402302000_95.5.386.8","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2014-051813"},{"key":"2024092304402302000_95.5.386.9","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit361"},{"key":"2024092304402302000_95.5.386.10","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2016-052626"},{"key":"2024092304402302000_95.5.386.11","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit360"},{"key":"2024092304402302000_95.5.386.12","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2013-051359"},{"key":"2024092304402302000_95.5.386.13","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/S0140-6736(01)06883-0","article-title":"Sexual behaviour in Britain: partnerships, practices, and HIV risk behaviours","volume":"358","author":"Johnson","year":"2001","journal-title":"The Lancet"},{"key":"2024092304402302000_95.5.386.14","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/S0140-6736(13)61947-9","article-title":"Prevalence, risk factors, and uptake of interventions for sexually transmitted infections in Britain: findings from the National Surveys of Sexual Attitudes and Lifestyles (Natsal)","volume":"382","author":"Sonnenberg","year":"2013","journal-title":"The Lancet"},{"key":"2024092304402302000_95.5.386.15","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-14-1333"},{"key":"2024092304402302000_95.5.386.16","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2015.90"},{"key":"2024092304402302000_95.5.386.17","unstructured":"King EM . Human papillomavirus epidemiology in men who have sex with men: Implications for a vaccine programme at sexual health clinics in the UK. PhD thesis. 2015. Available: http:\/\/discovery.ucl.ac.uk\/1473373\/12\/King_Eleanor_Megan_THESIS_17DEC15_FINAL.pd.%20REDACTEDf.pdf"},{"key":"2024092304402302000_95.5.386.18","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70080-3"},{"key":"2024092304402302000_95.5.386.19","first-page":"580","article-title":"Impact and Cost-effectiveness of Selective Human Papillomavirus Vaccination of Men Who Have Sex With Men","volume":"64","author":"Lin","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2024092304402302000_95.5.386.20","unstructured":"Welsh Government . HPV vaccine programme for gay men introduced. 2018. Available: http:\/\/gov.wales\/newsroom\/health-and-social-services\/2017\/170403hpv\/?lang=en [Accessed 25 Apr 2018]."},{"key":"2024092304402302000_95.5.386.21","unstructured":"HPV MSM. 2018. Available: http:\/\/www.immunisationscotland.org.uk\/vaccines-and-diseases\/hpvmsm.aspx [Accessed 25 Apr 2018]."},{"key":"2024092304402302000_95.5.386.22","unstructured":"HPV vaccination for men who have sex with men (MSM) programme. GOV.UK.. 2018. Available: https:\/\/www.gov.uk\/government\/collections\/hpv-vaccination-for-men-who-have-sex-with-men-msm-programme [Accessed 25 Apr 2018]."},{"key":"2024092304402302000_95.5.386.23","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2006.086439"},{"key":"2024092304402302000_95.5.386.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.pvr.2017.01.001"},{"key":"2024092304402302000_95.5.386.25","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2011-050306"},{"key":"2024092304402302000_95.5.386.26","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1016\/j.vaccine.2017.04.080","article-title":"Effectiveness of HPV vaccines against genital warts in women from Valencia, Spain","volume":"35","author":"Navarro-Illana","year":"2017","journal-title":"Vaccine"},{"key":"2024092304402302000_95.5.386.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.09.071"},{"key":"2024092304402302000_95.5.386.28","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jinf.2017.01.007","article-title":"No evidence for cross-protection of the HPV-16\/18 vaccine against HPV-6\/11 positivity in female STI clinic visitors","volume":"74","author":"Woestenberg","year":"2017","journal-title":"J Infect"},{"key":"2024092304402302000_95.5.386.29","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/infdis\/jiy249","article-title":"The Impact of the National HPV Vaccination Program in England Using the Bivalent HPV Vaccine: Surveillance of Type-Specific HPV in Young Females, 2010-2016","volume":"218","author":"Mesher","year":"2018","journal-title":"J Infect Dis"},{"key":"2024092304402302000_95.5.386.30","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30468-1"},{"key":"2024092304402302000_95.5.386.31","unstructured":"Public Health England . Sexually transmitted infections and screening for chlamydia in England, 2017. Health Prot Rep 2018;12."},{"key":"2024092304402302000_95.5.386.32","unstructured":"Joint Committee on Vaccination and Immunisation . Statement on HPV vaccination. 2018. Available: https:\/\/www.gov.uk\/government\/publications\/jcvi-statement-extending-the-hpv-vaccination-programme-conclusions"}],"container-title":["Sexually Transmitted Infections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/sextrans-2018-053786","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T11:41:07Z","timestamp":1727091667000},"score":1,"resource":{"primary":{"URL":"https:\/\/sti.bmj.com\/lookup\/doi\/10.1136\/sextrans-2018-053786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,5]]},"references-count":32,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,7,18]]},"published-print":{"date-parts":[[2019,8]]}},"alternative-id":["10.1136\/sextrans-2018-053786"],"URL":"https:\/\/doi.org\/10.1136\/sextrans-2018-053786","relation":{},"ISSN":["1368-4973","1472-3263"],"issn-type":[{"value":"1368-4973","type":"print"},{"value":"1472-3263","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,5]]}}}